- Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.
Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.
Journal of oncology (2010-07-17)
Thomas N Seyfried, Purna Mukherjee
PMID20634908
RÉSUMÉ
Progression of malignant brain tumors is dependent upon vascularity and is associated with altered ganglioside composition and distribution. Evidence is reviewed showing that the simple monosialoganglioside, GM3, possesses powerful antiangiogenic action against the highly vascularized CT-2A mouse astrocytoma, which primarily expresses complex gangliosides. Brain tumors expressing high levels of GM3 are generally less vascularized and grow slower than tumors that express low levels of GM3. GM3 inhibits angiogenesis through autocrine and paracrine effects on vascular endothelial growth factor (VEGF) and associated receptors. GM3 should be a clinically useful compound for managing brain tumor angiogenesis.
MATÉRIAUX
Référence du produit
Marque
Description du produit
Sigma-Aldrich
Lignée de cellules de gliome de souris CT-2A, CT-2A mouse glioma cell line is a valuable mouse model for therapeutic research on brain malignancies.
Sigma-Aldrich
CT-2A-Luc Mouse Glioma Cell Line, CT-2A-Luc mouse glioma cell line is a valuable mouse model for therapeutic research on brain malignancies.